Stay updated on Fruquintinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays Revision: v3.3.4, replacing the previous v3.3.3 label.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a unified 'Locations' section listing participating states (AZ, CA, CO, FL, MN, MO, TN, TX) and removed the prior per-state 'Arizona Locations', 'California Locations', etc., with revision: v3.3.3.SummaryDifference0.8%

- Check53 days agoChange DetectedAdded a note that publications are automatically filled from PubMed. Updated the page revision to v3.3.2; the prior PubMed sourcing description was removed.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the general government-funding notice regarding NIH/Clinical Center operations, which does not alter any trial details, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange DetectedThe screenshots indicate only minor UI/formatting adjustments and an updated timestamp, with no changes to core study details, eligibility criteria, outcomes, or safety information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check103 days agoChange DetectedAdded a government-status notice and updated version to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference2%

Stay in the know with updates to Fruquintinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.